Approval · Notice of Compliance 11713 · 2010
OLESTYR: Notice of Compliance 11713
Issued September 16, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11713
- Date
- September 16, 2010
- Company
- Mm Therapeutics IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antihypercholesterolemic / Antidiarrheal
Products in this notice
Medicinal ingredients
- CHOLESTYRAMINE RESIN 4 G per 5G
- CHOLESTYRAMINE RESIN 4 G per 9G